APA (7th ed.) Citation

C, R., B, S., C, S., JH, M., N, A., R, H., . . . M, B. (2025). Single or Double Induction With 7 + 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: The Randomized DaunoDouble Trial by the Study Alliance Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 43(1), 65. https://doi.org/10.1200/JCO.24.00235

Chicago Style (17th ed.) Citation

C, Röllig, et al. "Single or Double Induction With 7 + 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: The Randomized DaunoDouble Trial by the Study Alliance Leukemia." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 43, no. 1 (2025): 65. https://doi.org/10.1200/JCO.24.00235.

MLA (9th ed.) Citation

C, Röllig, et al. "Single or Double Induction With 7 + 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: The Randomized DaunoDouble Trial by the Study Alliance Leukemia." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 43, no. 1, 2025, p. 65, https://doi.org/10.1200/JCO.24.00235.